{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T17:57:33Z","timestamp":1768586253287,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010272","name":"Zarqa University","doi-asserted-by":"crossref","award":["M4-2022"],"award-info":[{"award-number":["M4-2022"]}],"id":[{"id":"10.13039\/501100010272","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10822-025-00665-6","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T09:50:38Z","timestamp":1761299438000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification and biological assessment of amino benzoxazole derivatives as KDR inhibitors and potential anti-cancer agents"],"prefix":"10.1007","volume":"39","author":[{"given":"Ali","family":"Khudhir","sequence":"first","affiliation":[]},{"given":"Mahmoud A.","family":"Al-Sha\u2019er","sequence":"additional","affiliation":[]},{"given":"Mahmoud A.","family":"Alelaimat","sequence":"additional","affiliation":[]},{"given":"Raed","family":"Khashan","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"665_CR1","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ejmech.2019.06.054","volume":"179","author":"X Yuan","year":"2019","unstructured":"Yuan X, Yang Q, Liu T, Li K, Liu Y, Zhu C et al (2019) Design, synthesis, and in vitro evaluation of 6-amide-2-aryl benzoxazole\/benzimidazole derivatives against tumor cells by inhibiting VEGFR-2 kinase. Eur J Med Chem 179:147\u2013165","journal-title":"Eur J Med Chem"},{"key":"665_CR2","unstructured":"N LP, T MP, Vijayan M (2015) Design, synthesis and biological evaluation of benzoxazole substituted azetidinone derivatives as anticancer agents. World J Pharm Res 10:950"},{"key":"665_CR3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1146\/annurev.bi.56.070187.003031","volume":"56","author":"A Edelman","year":"1987","unstructured":"Edelman A (1987) Protein serine threonine kinases. Annu Rev Biochem 56:567\u2013613","journal-title":"Annu Rev Biochem"},{"key":"665_CR4","unstructured":"Wheelar D (2004) Protein kinase C signal transduction pathways to the development of squamous cell carcinoma and a myeloproliferative-like disease"},{"key":"665_CR5","doi-asserted-by":"crossref","unstructured":"Avruch J (1998) Insulin signal transduction through protein kinase cascades. Cellular BiochemistT)l. Ktuwel\u2019 Academic Publishers","DOI":"10.1007\/978-1-4615-5647-3_4"},{"key":"665_CR6","doi-asserted-by":"crossref","unstructured":"Hunter T (1995) Protein kinases and phosphatases: the Yin and Yang of protein phosphorylation and signaling review. Cell","DOI":"10.1016\/0092-8674(95)90405-0"},{"key":"665_CR7","doi-asserted-by":"crossref","unstructured":"Noble MEM, Endicott JA, Johnson LN (2004) Protein Kinase inhibitors: insights into drug design from structure. Science (1979) pp 1800\u20135","DOI":"10.1126\/science.1095920"},{"key":"665_CR8","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/gtc.12022","volume":"18","author":"D Kitagawa","year":"2013","unstructured":"Kitagawa D, Yokota K, Gouda M, Narumi Y, Ohmoto H, Nishiwaki E et al (2013) Activity-based kinase profiling of approved tyrosine kinase inhibitors. Genes Cells 18:110\u2013122","journal-title":"Genes Cells"},{"key":"665_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6446(02)02290-0","author":"G Scapin","year":"2002","unstructured":"Scapin G (2002) Structural biology in drug design:selective protein kinase inhibitors. Drug Discov Today. https:\/\/doi.org\/10.1016\/S1359-6446(02)02290-0","journal-title":"Drug Discov Today"},{"key":"665_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.14712\/fb2006052040137","volume":"52","author":"I Shchemelinin","year":"2006","unstructured":"Shchemelinin I, \u0160efc L, Ne\u010das E (2006) Protein kinase inhibitors. Folia Biol (Praha) 52:137\u2013148","journal-title":"Folia Biol (Praha)"},{"key":"665_CR11","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nm0603-669","volume":"9","author":"N Ferrara","year":"2003","unstructured":"Ferrara N, Gerber H-P, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9:669\u2013676","journal-title":"Nat Med"},{"key":"665_CR12","doi-asserted-by":"publisher","DOI":"10.4155\/fmc.12.121","author":"L Huang","year":"2012","unstructured":"Huang L, Huang Z, Bai Z, Xie R, Sun L, Lin K (2012) Development and strategies of VEGFR-2\/KDR inhibitors. Future Med Chem. https:\/\/doi.org\/10.4155\/fmc.12.121","journal-title":"Future Med Chem"},{"key":"665_CR13","doi-asserted-by":"crossref","unstructured":"Liao D, Johnson RS (2007) Hypoxia: a key regulator of angiogenesis in cancer. Cancer and Metastasis Reviews pp 281\u201390","DOI":"10.1007\/s10555-007-9066-y"},{"key":"665_CR14","doi-asserted-by":"publisher","first-page":"4351","DOI":"10.1021\/jm070034i","volume":"50","author":"MH Potashman","year":"2007","unstructured":"Potashman MH, Bready J, Coxon A, Demelfi TM, DiPietro L, Doerr N et al (2007) Design, synthesis, and evaluation of orally active benzimidazoles and benzoxazoles as vascular endothelial growth factor-2 receptor tyrosine kinase inhibitors. J Med Chem 50:4351\u20134373","journal-title":"J Med Chem"},{"key":"665_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.medidd.2019.100009","volume":"2","author":"SJ Modi","year":"2019","unstructured":"Modi SJ, Kulkarni VM (2019) Vascular endothelial growth factor receptor (VEGFR-2)\/KDR inhibitors: medicinal chemistry perspective. Med Drug Discov 2:100009","journal-title":"Med Drug Discov"},{"key":"665_CR16","doi-asserted-by":"crossref","unstructured":"Kamal U, Javed NM, Arun K (2020) Biological potential of benzoxazole derivatives: an updated review. Asian J Pharm Clin Res 28\u201341","DOI":"10.22159\/ajpcr.2020.v13i8.37958"},{"key":"665_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s43094-020-00115-0","author":"T Ghoshal","year":"2020","unstructured":"Ghoshal T, Patel TM (2020) Anticancer activity of benzoxazole derivative (2015 onwards): a review. Futur J Pharm Sci. https:\/\/doi.org\/10.1186\/s43094-020-00115-0","journal-title":"Futur J Pharm Sci"},{"key":"665_CR18","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jinorgbio.2010.01.011","volume":"104","author":"J Jiang","year":"2010","unstructured":"Jiang J, Tang X, Dou W, Zhang H, Liu W, Wang C et al (2010) Synthesis and characterization of the ligand based on benzoxazole and its transition metal complexes: DNA-binding and antitumor activity. J Inorg Biochem 104:583\u2013591","journal-title":"J Inorg Biochem"},{"key":"665_CR19","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1016\/j.ejmech.2008.06.027","volume":"44","author":"V Klime\u0161ov\u00e1","year":"2009","unstructured":"Klime\u0161ov\u00e1 V, Ko\u010d\u00ed J, Waisser K, Kaustov\u00e1 J, M\u00f6llmann U (2009) Preparation and in vitro evaluation of benzylsulfanyl benzoxazole derivatives as potential antituberculosis agents. Eur J Med Chem 44:2286\u20132293","journal-title":"Eur J Med Chem"},{"key":"665_CR20","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.bmc.2018.01.007","volume":"26","author":"A Kaur","year":"2018","unstructured":"Kaur A, Pathak DP, Sharma V, Wakode S (2018) Synthesis, biological evaluation and docking study of a new series of di-substituted benzoxazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents. Bioorg Med Chem 26:891\u2013902","journal-title":"Bioorg Med Chem"},{"key":"665_CR21","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1016\/j.bmc.2006.01.054","volume":"14","author":"SM Sondhi","year":"2006","unstructured":"Sondhi SM, Singh N, Kumar A, Lozach O, Meijer L (2006) Synthesis, anti-inflammatory, analgesic and kinase (CDK-1, CDK-5 and GSK-3) inhibition activity evaluation of benzimidazole\/benzoxazole derivatives and some Schiff\u2019s bases. Bioorg Med Chem 14:3758\u20133765","journal-title":"Bioorg Med Chem"},{"key":"665_CR22","doi-asserted-by":"crossref","unstructured":"Singh S, Veeraswamy G, Bhattarai D, Goo J-I, Lee K, Hoi Y (2015) Pharmacologically active benzoxazoles recent advances in the development of pharmacologically active compounds that contain aB enzoxazole Scaffold [Internet]. Asian J Org Chem","DOI":"10.1002\/chin.201608233"},{"key":"665_CR23","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1016\/j.ejmech.2011.03.017","volume":"46","author":"RV Satyendra","year":"2011","unstructured":"Satyendra RV, Vishnumurthy KA, Vagdevi HM, Rajesh KP, Manjunatha H, Shruthi A (2011) Synthesis, in vitro antioxidant, anthelmintic and molecular docking studies of novel dichloro substituted benzoxazole-triazolo-thione derivatives. Eur J Med Chem 46:3078\u20133084","journal-title":"Eur J Med Chem"},{"key":"665_CR24","doi-asserted-by":"publisher","first-page":"6538","DOI":"10.1016\/j.bmcl.2010.09.038","volume":"20","author":"Z Yang","year":"2010","unstructured":"Yang Z, Fairfax DJ, Maeng JH, Masih L, Usyatinsky A, Hassler C et al (2010) Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists. Bioorg Med Chem Lett 20:6538\u20136541","journal-title":"Bioorg Med Chem Lett"},{"key":"665_CR25","doi-asserted-by":"crossref","unstructured":"Luo B, Li D, Zhang AL, Gao JM (2018) Synthesis, antifungal activities and molecular docking studies of benzoxazole and benzothiazole derivatives. Molecules 23","DOI":"10.3390\/molecules23102457"},{"key":"665_CR26","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1080\/14756366.2021.2015343","volume":"37","author":"H Elkady","year":"2022","unstructured":"Elkady H, Elwan A, El-Mahdy HA, Doghish AS, Ismail A, Taghour MS et al (2022) New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies. J Enzyme Inhib Med Chem 37:403\u2013416","journal-title":"J Enzyme Inhib Med Chem"},{"key":"665_CR27","doi-asserted-by":"crossref","unstructured":"Abudayah A, Daoud S, Al\u2010Sha\u2019er MA, Omar Taha M (2022) pharmacophore modeling of targets infested with activity cliffs via molecular dynamics simulation coupled with QSAR and comparison with other pharmacophore generation methods: KDR as case study. Mol Inform 41","DOI":"10.1002\/minf.202200049"},{"key":"665_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13065-018-0459-5","volume":"12","author":"S Kakkar","year":"2018","unstructured":"Kakkar S, Tahlan S, Lim SM, Ramasamy K, Mani V, Shah SAA et al (2018) Benzoxazole derivatives: design, synthesis and biological evaluation. Chem Cent J 12:92","journal-title":"Chem Cent J"},{"key":"665_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/srep24460","volume":"6","author":"MA Aziz","year":"2016","unstructured":"Aziz MA, Serya RAT, Lasheen DS, Abdel-Aziz AK, Esmat A, Mansour AM et al (2016) Discovery of potent VEGFR-2 inhibitors based on Furopyrimidine and Thienopyrimidne scaffolds as cancer targeting agents. Sci Rep 6:24460","journal-title":"Sci Rep"},{"key":"665_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.201900113","author":"AA El-Helby","year":"2019","unstructured":"El-Helby AA, Sakr H, Eissa IH, Abulkhair H, Al-Karmalawy AA, El-Adl K (2019) Design, synthesis, molecular docking, and anticancer activity of benzoxazole derivatives as VEGFR-2 inhibitors. Arch Pharm (Weinheim). https:\/\/doi.org\/10.1002\/ardp.201900113","journal-title":"Arch Pharm (Weinheim)"},{"key":"665_CR31","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1016\/S0968-0896(02)00327-9","volume":"10","author":"D Kumar","year":"2002","unstructured":"Kumar D, Jacob MR, Reynolds MB, Kerwin SM (2002) Synthesis and evaluation of anticancer benzoxazoles and benzimidazoles related to UK-1. Bioorg Med Chem 10:3997\u20134004","journal-title":"Bioorg Med Chem"},{"key":"665_CR32","doi-asserted-by":"publisher","first-page":"102","DOI":"10.7164\/antibiotics.54.102","volume":"54","author":"S Sato","year":"2001","unstructured":"Sato S, Kajiura T, Noguchi M, Takehana K, Kobayashi T, Tsuji T (2001) AJI9561, a new cytotoxic benzoxazole derivative produced by Streptomyces sp. J Antibiot (Tokyo) 54:102\u2013104","journal-title":"J Antibiot (Tokyo)"},{"key":"665_CR33","doi-asserted-by":"publisher","first-page":"14247","DOI":"10.1021\/acsomega.3c01273","volume":"8","author":"MA Alelaimat","year":"2023","unstructured":"Alelaimat MA, Al-Sha\u2019er MA, Basheer HA (2023) Novel sulfonamide-triazine hybrid derivatives: docking, synthesis, and biological evaluation as anticancer agents. ACS Omega 8:14247\u201314263","journal-title":"ACS Omega"},{"key":"665_CR34","first-page":"1","volume":"71","author":"AH Abdullah","year":"2024","unstructured":"Abdullah AH, Alarareh AK, Al-Sha\u2019er MA, Habashneh AY, Awwadi FF, Bardaweel SK (2024) Docking, synthesis, and anticancer assessment of novel quinoline-amidrazone hybrids. Pharmacia 71:1\u201312","journal-title":"Pharmacia"},{"key":"665_CR35","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00044-023-03057-3","volume":"32","author":"MA Al-Sha\u2019er","year":"2023","unstructured":"Al-Sha\u2019er MA, Taha M, Alelaimat MA (2023) Development of phosphoinositide 3-kinase delta (PI3K\u03b4) inhibitors as potential anticancer agents through the generation of ligand-based pharmacophores and biological screening. Med Chem Res 32:1109\u20131121","journal-title":"Med Chem Res"},{"key":"665_CR36","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.4314\/tjpr.v21i10.15","volume":"21","author":"L Swellmeen","year":"2022","unstructured":"Swellmeen L, Basheer HA, Uzrail A, Sallam H, Al-Hiari Y, Alkilani A (2022) Targeting GSK-3\u03b2 enzyme by diazepino-quinolone derivatives. Trop J Pharm Res 21:2147\u20132151","journal-title":"Trop J Pharm Res"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00665-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-025-00665-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00665-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T06:38:43Z","timestamp":1764398323000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-025-00665-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["665"],"URL":"https:\/\/doi.org\/10.1007\/s10822-025-00665-6","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"22 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"While preparing this work, the author(s) used Quill Bot and Grammarly to improve the grammar and check for spelling errors. After using this tool\/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the publication's content.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI and AI-assisted technologies in the writing process"}}],"article-number":"93"}}